| Literature DB >> 22883982 |
Matthias Preusser1, Frank Winkler, Laurence Collette, Sven Haller, Sandrine Marreaud, Riccardo Soffietti, Martin Klein, Jaap C Reijneveld, Jörg-Christian Tonn, Brigitta G Baumert, Paula Mulvenna, Dirk Schadendorf, Renata Duchnowska, Anna Sophie Berghoff, Nancy Lin, David A Cameron, Yazid Belkacemi, Jacek Jassem, Damien C Weber.
Abstract
Brain metastases (BM) occur in a significant proportion of cancer patients and are associated with considerable morbidity and poor prognosis. The trial design in BM patients is particularly challenging, as many disease and patient variables, statistical issues, and the selection of appropriate end-points have to be taken into account. During a meeting organised on behalf of the European Organisation for Research and Treatment of Cancer (EORTC), methodological aspects of trial design in BM were discussed. This paper summarises the issues and potential trial strategies discussed during this meeting and may provide some guidance for the design of trials in BM patients.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22883982 DOI： 10.1016/j.ejca.2012.07.002
Source DB: PubMed Journal: Eur J Cancer ISSN： 0959-8049 Impact factor: 9.162